A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI

Clinical trial NCT02182440 · COMPLETED

Trial details

NCT number: NCT02182440
Sponsor: AM-Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Kidney Injury

Start date: 2014-12-18
Primary completion: 2017-05-25
Enrollment: 301

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.